Soluble HSPB1 regulates VEGF-mediated angiogenesis through their direct interaction

Area of Science:

• Cell Biology
• Molecular Biology
• Oncology

Background:

• Endothelial cell function is crucial for regulating angiogenesis in physiological and pathological processes.
• Vascular Endothelial Growth Factor (VEGF) is a key regulator of angiogenesis.
• The role of heat shock proteins in angiogenesis is not fully understood.

Purpose of the Study:

• To investigate the role of soluble heat shock protein beta-1 (HSPB1) in regulating angiogenic balance.
• To elucidate the interaction between HSPB1 and VEGF in endothelial cells.
• To determine the therapeutic potential of targeting HSPB1 in cancer and wound healing.

Main Methods:

• Co-culture of tumor endothelial cells (ECs) with tumor cells.
• VEGF-mediated phosphorylation assays.
• In vivo studies using a mouse sarcoma model and CT26 colon carcinoma.
• Adenovirus-mediated overexpression of HSPB1.
• Neutralization of HSPB1.

Main Results:

• Soluble HSPB1 is primarily released from endothelial cells and directly interacts with VEGF.
• VEGF-mediated phosphorylation of intracellular HSPB1 inhibits its secretion and binding activity.
• Inhibition of HSPB1 secretion promotes VEGF-driven angiogenesis.
• Neutralization of HSPB1 enhances tumor growth and angiogenesis in a mouse sarcoma model.
• Overexpression of HSPB1 suppresses lung metastases, while its neutralization promotes wound healing.

Conclusions:

• HSPB1 plays a critical role in maintaining angiogenic balance.
• The interaction between HSPB1 and VEGF is a key determinant of physiological and pathological angiogenesis.
• Targeting HSPB1 represents a potential therapeutic strategy for cancer and wound healing.